- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 0.9% sterile, unpreserved saline
Total 2935 results
-
Tri-Service General HospitalCompleted
-
NovaBay Pharmaceuticals, Inc.CompletedUrinary Catheter Blockage and EncrustationUnited States
-
Stealth BioTherapeutics Inc.CompletedHealthy VolunteersUnited States
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Arrowhead PharmaceuticalsCompletedHypertriglyceridemia | Familial ChylomicronemiaAustralia, Canada, New Zealand
-
Alnylam PharmaceuticalsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Spain, United Kingdom
-
Alnylam PharmaceuticalsCompletedTransthyretin-mediated Amyloidosis (ATTR Amyloidosis)United Kingdom
-
Alnylam PharmaceuticalsThe Medicines CompanyCompletedHypercholesterolemiaUnited Kingdom
-
Alnylam PharmaceuticalsCompletedTTR-mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedElevated LDL-Cholesterol (LDL-C)United Kingdom
-
Alnylam PharmaceuticalsCompletedTransthyretin Mediated Amyloidosis (ATTR)United Kingdom, France, Portugal, Sweden
-
BioAegis Therapeutics Inc.Not yet recruitingInfections | Acute Respiratory Distress Syndrome
-
Alnylam PharmaceuticalsCompletedAmyloid Neuropathies | Amyloid Neuropathies, Familial | Amyloidosis, Hereditary | Transthyretin (TTR) Mediated Familial Amyloidotic Cardiomyopathy (FAC) | Amyloidosis, Hereditary, Transthyretin-Related | Familial Transthyretin Cardiac AmyloidosisUnited States, France, Italy, Spain, Canada, Germany, Belgium, Sweden, United Kingdom
-
Alnylam PharmaceuticalsCompletedAcute Intermittent PorphyriaUnited States, United Kingdom, Sweden
-
Alnylam PharmaceuticalsActive, not recruitingTransthyretin Amyloidosis (ATTR) With CardiomyopathyUnited States, Poland, Argentina, Australia, Belgium, France, Germany, Japan, Netherlands, Portugal, Spain, Sweden, United Kingdom, Canada, Czechia, Denmark, Hungary, Ireland, Norway, Korea, Republic of, Austria, Croatia, Israel, Latvia, Lithuan... and more
-
Arrowhead PharmaceuticalsCompletedNon-alcoholic SteatohepatitisNew Zealand
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary Hyperoxaluria Type 3United States, Germany, Netherlands, United Kingdom
-
Alnylam PharmaceuticalsCompletedA Study of the Safety, Tolerability and Pharmacokinetics of ALN-TTR02 in Japanese Healthy VolunteersTransthyretin (TTR)-Mediated AmyloidosisUnited Kingdom
-
Alnylam PharmaceuticalsCompletedAmyloid Neuropathies | Amyloid Neuropathies, Familial | TTR-mediated Amyloidosis | Amyloidosis, Hereditary | Amyloidosis, Hereditary, Transthyretin-Related | Familial Amyloid PolyneuropathiesUnited States, Canada, Argentina, Australia, Bulgaria, Cyprus, Italy, Japan, Malaysia, Mexico, Netherlands, Portugal, Spain, Sweden, Germany, France, Brazil, Turkey, Korea, Republic of, Taiwan, United Kingdom
-
Alnylam PharmaceuticalsCompleted
-
Ionis Pharmaceuticals, Inc.Akcea TherapeuticsCompleted
-
University Hospital Inselspital, BerneCompletedCardiovascular Diseases | Valvular Heart DiseaseSwitzerland
-
Prove pharmRecruitingUreter InjuryUnited States
-
Arrowhead PharmaceuticalsCompleted
-
Alnylam PharmaceuticalsTerminatedAntitrypsin Deficiency Liver DiseaseUnited Kingdom
-
SanofiCompletedHemophilia A | Hemophilia BBulgaria, Switzerland, United Kingdom, United States, Russian Federation
-
Pulmatrix Inc.Completed
-
Prove pharmRecruiting
-
Moberg Pharma ABCompleted
-
BiogenCompletedAcute Optic NeuritisSweden, Spain, United Kingdom, Germany, Canada, Denmark, Hungary, Belgium, Czechia, Australia, Italy
-
Ionis Pharmaceuticals, Inc.BayerCompletedEnd-stage Renal Disease (ESRD)Canada
-
GlaxoSmithKlineCompleted
-
European Vaccine InitiativeUniversity of Oxford; Malaria Research and Training Center, Bamako, MaliNot yet recruitingHealthy Women of Child Bearing Potential
-
LipimetiX Development, LLCCompletedHypercholesterolemia | Hyperlipoproteinemia Type IIAustralia
-
Novo Nordisk A/SCompletedKidney Diseases | Urologic Diseases | Genetic Disease | Primary Hyperoxaluria Type 1 (PH1) | Primary Hyperoxaluria Type 2 (PH2)Poland, United States, United Kingdom, New Zealand, Australia, Canada, France, Germany, Israel, Italy, Japan, Lebanon, Netherlands, Romania, Spain
-
Alnylam PharmaceuticalsTerminatedHepatitis B | Chronic Hepatitis B | Hepatitis B, Chronic | HBV | Hepatitis B InfectionUnited Kingdom, New Zealand, Singapore, Korea, Republic of, Australia, Hong Kong
-
Atox Bio LtdBiomedical Advanced Research and Development AuthorityCompletedNecrotizing Fasciitis | Necrotizing Soft Tissue Infections | Fournier's GangreneUnited States, France
-
Amorepacific CorporationCompleted
-
MiMedx Group, Inc.Withdrawn
-
Ionis Pharmaceuticals, Inc.WithdrawnGeographic Atrophy | Age Related Macular DegenerationAustralia, United States, New Zealand
-
Instituto Tecnologico y de Estudios Superiores...Tecnologico de MonterreyCompleted
-
University of Missouri-ColumbiaWithdrawnLumbar Spine Degeneration | Cervical Spine DegenerationUnited States
-
Atox Bio LtdTerminatedAcute Kidney Injury | Peritonitis | Necrotizing Soft Tissue InfectionUnited States, France
-
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co LtdCompleted
-
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co LtdCompleted
-
The George InstituteUniversity of Sydney; Fresenius Kabi; Australian and New Zealand Intensive Care...Completed
-
Arrowhead PharmaceuticalsCompletedHepatitis BAustralia, Hong Kong, New Zealand
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...Germans Trias i Pujol Hospital; Grifols Biologicals, LLC; Banc de Sang i Teixits and other collaboratorsCompletedSARS-CoV-2 Infection | Safety and EfficacySpain
-
Dr. Reddy's Laboratories LimitedTKL Research, Inc.; AccelovanceCompletedHead LiceUnited States
-
Vanderbilt University Medical CenterActive, not recruitingPostural Tachycardia SyndromeUnited States